The prognostic value of mitotic activity index (MAI), phosphohistone H3 (PPH3), cyclin B1, cyclin A, and Ki67, alone and in combinations, in node-negative premenopausal breast cancer.
about
Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer: A meta-analysis.Initiation and termination of DNA replication during S phase in relation to cyclins D1, E and A, p21WAF1, Cdt1 and the p12 subunit of DNA polymerase δ revealed in individual cells by cytometryPathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional studyProgesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growthClinical implications of proliferation activity in T1 or T2 male gastric cancer patientsAssociation Between Phosphorylated Histone H3 and Oncotype DX Recurrence Scores in Breast Cancer.HDAC-inhibition counteracts everolimus resistance in renal cell carcinoma in vitro by diminishing cdk2 and cyclin A.High phosphohistone H3 expression correlates with adverse clinical, biological, and pathological factors in neuroblastomasThe value of phosphohistone H3 as a proliferation marker for evaluating invasive breast cancers: A comparative study with Ki67.G protein-coupled estrogen receptor 1 (GPER 1) mediates estrogen-induced, proliferation of leiomyoma cells.Phosphohistone H3 outperforms Ki67 as a marker of outcome for breast cancer patients.
P2860
Q33672809-ED791116-8C6B-4B23-BA54-95D8D6F7FE46Q34480026-85B7DE0B-23A1-4D5C-AEEC-22E364F39D3FQ34567461-2592CD7B-52E6-455A-83F8-D37B8D7A9F7BQ35000657-DB35C383-630A-4885-BB21-8D9515186939Q36356936-7378CBCF-629D-4489-AE98-EDEA6064DD62Q37488438-770D525D-C89D-4D9E-AB83-BC2DCF093E5EQ38984146-DA49676B-933B-4A9D-B014-E5BB71C4F443Q41826142-9C8F2B52-B92B-4607-BE1E-D399815016A7Q42371501-FB97AFE8-E51E-4492-BEF3-FA3CE7DAA811Q52913542-E32415AA-5905-4953-8981-473C9207205EQ53599540-2CA7213E-6C3C-4633-9B18-328B08F32E25
P2860
The prognostic value of mitotic activity index (MAI), phosphohistone H3 (PPH3), cyclin B1, cyclin A, and Ki67, alone and in combinations, in node-negative premenopausal breast cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The prognostic value of mitoti ...... e premenopausal breast cancer.
@ast
The prognostic value of mitoti ...... e premenopausal breast cancer.
@en
type
label
The prognostic value of mitoti ...... e premenopausal breast cancer.
@ast
The prognostic value of mitoti ...... e premenopausal breast cancer.
@en
prefLabel
The prognostic value of mitoti ...... e premenopausal breast cancer.
@ast
The prognostic value of mitoti ...... e premenopausal breast cancer.
@en
P2093
P2860
P50
P1433
P1476
The prognostic value of mitoti ...... e premenopausal breast cancer.
@en
P2093
Carina Strand
Cecilia Ahlin
Dorthe Grabau
Einar Gudlaugsson
Kristina Lövgren
Marie Klintman
Marie-Louise Fjällskog
Mårten Fernö
Pär-Ola Bendahl
Sanda Beglerbegovic
P2860
P304
P356
10.1371/JOURNAL.PONE.0081902
P407
P577
2013-12-04T00:00:00Z